New drug ZT003 tested for safety in first human trial
NCT ID NCT07184502
First seen Jun 27, 2026 · Last updated Jul 28, 2026 · Updated 2 times
Summary
This early-stage study tests the safety and tolerability of an investigational drug called ZT003 in healthy adults and those who are overweight or obese. About 76 participants will receive either the drug or a placebo to check for side effects and how the drug moves through the body. The goal is to gather safety data, not to treat any disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Nucleus Network
NOT_YET_RECRUITINGMelbourne, Australia
-
Nucleus Network Brisbane
RECRUITINGBrisbane, Queensland, Australia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new oral drug change future treatments? early safety trial begins
- Can brain scans unlock the secret to hearing in crowded rooms?
- Can a Light-Guided device make arterial sticks easier?
- Water workouts could be the key to back pain relief
- Could everyday disinfectants be harming us? a new study investigates
- Can a new drug keep the Heart's beat steady? trial puts verducatib to the test